• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丹曲林钠所致肝炎。

Hepatitis from dantrolene sodium.

作者信息

Wilkinson S P, Portmann B, Williams R

出版信息

Gut. 1979 Jan;20(1):33-6. doi: 10.1136/gut.20.1.33.

DOI:10.1136/gut.20.1.33
PMID:761834
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1418951/
Abstract

The clinical course and histological changes in the liver during a presumed adverse reaction to the drug dantrolene sodium are described in four patients. After a typical prodrome one developed a moderately severe hepatitis-like illness. Another also had a prodrome but never became jaundiced. In the other two, abnormal liver function tests were detected on routine screening. In each case liver biopsy showed changes typical of an acute hepatitis, but the severity was unrelated to the clinical presentation. In addition, there were also changes in the portal tracts resembling ascending cholangitis. In each case liver function tests returned to normal after withdrawing treatment with dantrolene.

摘要

本文描述了4例患者在使用丹曲林钠药物后可能出现不良反应期间肝脏的临床病程和组织学变化。在典型的前驱症状后,1例患者发展为中度严重的肝炎样疾病。另1例患者也有前驱症状,但从未出现黄疸。另外2例患者在常规筛查中发现肝功能检查异常。在每例患者中,肝活检均显示出急性肝炎的典型变化,但严重程度与临床表现无关。此外,门静脉区域也有类似上行性胆管炎的变化。在每例患者中,停用丹曲林治疗后肝功能检查恢复正常。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c2e/1418951/e7578b044f2c/gut00446-0043-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c2e/1418951/260aea5364ed/gut00446-0042-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c2e/1418951/4cd6d29e98fd/gut00446-0043-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c2e/1418951/e7578b044f2c/gut00446-0043-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c2e/1418951/260aea5364ed/gut00446-0042-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c2e/1418951/4cd6d29e98fd/gut00446-0043-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c2e/1418951/e7578b044f2c/gut00446-0043-b.jpg

相似文献

1
Hepatitis from dantrolene sodium.丹曲林钠所致肝炎。
Gut. 1979 Jan;20(1):33-6. doi: 10.1136/gut.20.1.33.
2
Dantrolene hepatitis.丹曲林肝炎
JAMA. 1976 Apr 12;235(15):1590-1.
3
Letter: Hepatitis associated with dantrolene sodium.信函:与丹曲林钠相关的肝炎
Ann Intern Med. 1976 Jan;84(1):53-4. doi: 10.7326/0003-4819-84-1-53.
4
Dantrolene-associated hepatic injury. Incidence and character.
Gastroenterology. 1977 Apr;72(4 Pt 1):610-6.
5
Letter: Dantrolene hepatitis.信件:丹曲林肝炎。
JAMA. 1976 Sep 20;236(12):1351. doi: 10.1001/jama.236.12.1351c.
6
[Fatal toxic hepatitis associated with administration of dantrolene (author's transl)].与丹曲林给药相关的致命性中毒性肝炎(作者译)
Acta Neurol Belg. 1980;80(6):336-47.
7
[Liver lesions induced by dihydralazine and propranolol].[肼屈嗪和普萘洛尔诱导的肝脏病变]
Zentralbl Allg Pathol. 1985;130(1):19-29.
8
Dantrolene sodium and hepatic injury.
Neurology. 1990 Sep;40(9):1427-32. doi: 10.1212/wnl.40.9.1427.
9
[Acute hepatitis and destructive cholangitis probably induced by amoxicillin-clavulanic acid combination].[急性肝炎和可能由阿莫西林-克拉维酸组合诱发的破坏性胆管炎]
Gastroenterol Clin Biol. 1999 Oct;23(10):1097-8.
10
Immune-related adverse reactions in the hepatobiliary system: second-generation check-point inhibitors highlight diverse histological changes.肝胆系统免疫相关不良反应:第二代检查点抑制剂凸显多样化的组织学改变。
Histopathology. 2020 Feb;76(3):470-480. doi: 10.1111/his.14000. Epub 2019 Dec 1.

引用本文的文献

1
Dantrolene-Induced Hepatitis: A Rare Culprit in the PICU.丹曲林诱发的肝炎:儿科重症监护病房中一个罕见的病因
J Pediatr Intensive Care. 2021 Jun;10(2):152-154. doi: 10.1055/s-0040-1710496. Epub 2020 Jun 5.
2
Drug-induced liver injury: is it somehow foreseeable?药物性肝损伤:在某种程度上可以预见吗?
World J Gastroenterol. 2009 Jun 21;15(23):2817-33. doi: 10.3748/wjg.15.2817.
3
Dantrolene.丹曲林

本文引用的文献

1
1-[(5-arylfurfurylidene)amino]hydantoins. A new class of muscle relaxants.1-[(5-芳基糠叉基)氨基]乙内酰脲。一类新型肌肉松弛剂。
J Med Chem. 1967 Sep;10(5):807-10. doi: 10.1021/jm00317a011.
2
Diphenylhydantoin sodium hepatitis.苯妥英钠肝炎
JAMA. 1968 Mar 18;203(12):1015-8. doi: 10.1001/jama.203.12.1015.
3
Letter: Hepatitis associated with dantrolene sodium.信函:与丹曲林钠相关的肝炎
Can Anaesth Soc J. 1984 Jan;31(1):61-75. doi: 10.1007/BF03011484.
4
Drug effects on the liver. An updated tabular compilation of drugs and drug-related hepatic diseases.药物对肝脏的影响。药物及药物相关肝病的最新表格汇编。
Dig Dis Sci. 1983 Jul;28(7):651-66. doi: 10.1007/BF01299927.
5
Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.丹曲林。对其药效学、药代动力学特性以及在恶性高热、抗精神病药物恶性综合征中的治疗用途的综述,并更新其在肌肉痉挛中的应用。
Drugs. 1986 Aug;32(2):130-68. doi: 10.2165/00003495-198632020-00003.
6
Multiple sclerosis. Current concepts in management.多发性硬化症。管理方面的当前概念。
Drugs. 1985 Jan;29(1):88-95. doi: 10.2165/00003495-198529010-00004.
7
Drug effects on the liver: a tabular compilation of drugs and drug-related hepatic diseases.药物对肝脏的影响:药物及药物相关肝病的表格汇编
Dig Dis Sci. 1979 Oct;24(10):785-96. doi: 10.1007/BF01317213.
Ann Intern Med. 1976 Jan;84(1):53-4. doi: 10.7326/0003-4819-84-1-53.
4
Dantrolene hepatitis.丹曲林肝炎
JAMA. 1976 Apr 12;235(15):1590-1.
5
Dantrolene-associated hepatic injury. Incidence and character.
Gastroenterology. 1977 Apr;72(4 Pt 1):610-6.